Clinical Trial Update: Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C

View source ↗

Summary

A completed clinical trial assessing telaprevir in combination with peginterferon alfa and ribavirin for genotype 1 chronic hepatitis C in individuals with a hi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Incivek (telaprevir)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Hepatitis, Chronic | Status: COMPLETED